# Pravastatin Corrects Endothelial Dysfunction in Ex Vivo Uterine Radial Arteries in Preeclampsia

**Authors:** Nathan M. Luque, Leo Leader, Sandra M. Lowe, Steven D. Horrowitz, Marianne Tare, Victoria Hinkley, Vladimir V. Matchkov, Maged M. Costantine, Irit Markus, Lu Liu, Shaun L. Sandow, Timothy V. Murphy

PMC · DOI: 10.1111/apha.70186 · 2026-03-11

## TL;DR

Pravastatin improves blood vessel function in arteries from preeclamptic pregnancies, suggesting it could be a potential treatment.

## Contribution

The study shows pravastatin can correct endothelial dysfunction in preeclampsia via NO and hyperpolarization mechanisms.

## Key findings

- Endothelium-dependent relaxation was impaired in preeclamptic arteries compared to normotensive ones.
- Pravastatin restored NO and hyperpolarization-mediated relaxation in preeclamptic arteries.
- Pravastatin increased caveolae density and endothelial-NOS expression in preeclamptic arteries.

## Abstract

Endothelium‐dependent relaxation in isolated uterine radial arteries from normotensive (NT) and preeclamptic (PE) pregnancies, and the acute effects of pravastatin in the latter vessels were assessed. Pravastatin is hypothesized to alleviate endothelial dysfunction in PE via modulating aspects of NO and endothelium‐derived hyperpolarization‐mediated relaxation.

Radial arteries isolated from the uterus of NT and PE pregnant patients were incubated with pravastatin (2 mM/6 h), methyl‐β‐cyclodextrin (10 mM/1 h) in vitro, or vehicle. Vessel function was determined with pressure myography, while related morphology and protein/mRNA expression were characterized using immunohistochemistry, electron microscopy, and qPCR.

Endothelium‐dependent, bradykinin‐induced NO‐mediated relaxation was impaired in radial arteries from PE compared to NT pregnancy, with a reduced intermediate‐ and large‐conductance Ca2+‐activated K+‐channel contribution. Endothelial small‐conductance Ca2+‐activated K+‐channel function and expression were increased in arteries from PE, compared to NT patients. Pravastatin restored NO and endothelium‐derived hyperpolarization‐mediated relaxation in arteries from PE women; potentially overcompensating overall endothelium‐dependent relaxation. Myoendothelial gap junction and endothelial caveolae density, and caveolin‐1 and endothelial‐NOS expression were decreased in arteries from PE relative to NT pregnancies and increased following pravastatin incubation. Caveolae density in NT patient arteries was reduced by methyl‐β‐cyclodextrin, while endothelial caveolae were increased in vessels from PE patients. Pravastatin incubation restored endothelial function via improved NO and endothelium‐derived hyperpolarization‐type mechanisms.

Pravastatin restored endothelium‐dependent relaxation in uterine radial arteries from PE pregnancies. Data support the therapeutic potential for pravastatin in treating PE, with ongoing trials determining the validity of its use in the clinical setting.

ClinicalTrials.gov identifier: NCT01717586

## Linked entities

- **Proteins:** CAV1 (caveolin 1)
- **Chemicals:** pravastatin (PubChem CID 54687), bradykinin (PubChem CID 439201)
- **Diseases:** preeclampsia (MONDO:0005081)

## Full-text entities

- **Genes:** CTH (cystathionine gamma-lyase) [NCBI Gene 1491] {aka CGL, CSE}, CAV1 (caveolin 1) [NCBI Gene 857] {aka BSCL3, CGL3, LCCNS, MSTP085, PPH3, VIP21}, KCNN4 (potassium calcium-activated channel subfamily N member 4) [NCBI Gene 3783] {aka DHS2, IK, IK1, IKCA1, KCA4, KCa3.1}, SGCB (sarcoglycan beta) [NCBI Gene 6443] {aka A3b, LGMD2E, LGMDR4, SGC}, NOS2 (nitric oxide synthase 2) [NCBI Gene 4843] {aka HEP-NOS, INOS, NOS, NOS2A}, CAV2 (caveolin 2) [NCBI Gene 858] {aka CAV}, GJB6 (gap junction protein beta 6) [NCBI Gene 10804] {aka CX30, DFNA3, DFNA3B, DFNB1B, ECTD2, ED2}, KNG1 (kininogen 1) [NCBI Gene 3827] {aka BDK, BK, HAE6, HK, HMWK, KNG}, HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase) [NCBI Gene 3156] {aka LDLCQ3, LGMDR28, MYPLG}, CSN3 (casein kappa) [NCBI Gene 1448] {aka CNS10, CSN10, CSNK, KCA}, KCNN3 (potassium calcium-activated channel subfamily N member 3) [NCBI Gene 3782] {aka KCa2.3, SK3, SKCA3, ZLS3, hSK3}, AVP (arginine vasopressin) [NCBI Gene 551] {aka ADH, ARVP, AVP-NPII, AVRP, VP}, CAVIN1 (caveolae associated protein 1) [NCBI Gene 284119] {aka CAVIN, CGL4, FKSG13, PTRF, cavin-1}, COX8A (cytochrome c oxidase subunit 8A) [NCBI Gene 1351] {aka COX, COX8, COX8-2, COX8L, MC4DN15, VIII}, NOS3 (nitric oxide synthase 3) [NCBI Gene 4846] {aka EC-NOS, ECNOS, MYMY8, NOSIII, cNOS, eNOS}, CAV3 (caveolin 3) [NCBI Gene 859] {aka LGMD1C, LQT9, MPDT, RMD2, VIP-21, VIP21}
- **Diseases:** inflammatory (MESH:D007249), fetal growth restriction (MESH:D005317), Preeclampsia (MESH:D011225), Endothelial Dysfunction (MESH:D014652), essential hypertension (MESH:D000075222), PE (MESH:C538543), proteinuria (MESH:D011507), hypertension (MESH:D006973), microvascular dysfunction (MESH:D017566), derived (MESH:C536408), coagulopathy (MESH:D001778), cardiovascular and metabolic disease (MESH:D002318), preterm births (MESH:D047928), placentation (MESH:D010922), Dysfunction (MESH:D006331), uterine dysfunction (MESH:D014591)
- **Chemicals:** L-NAME (MESH:D019331), MbetaCD (MESH:C108732), prostaglandin (MESH:D011453), 1-(2-Chlorophenyl)diphenylmethyl-1H-pyrazole (MESH:C411671), NO (MESH:D009569), Cholesterol (MESH:D002784), 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (MESH:C095284), prostacyclin (MESH:D011464), PI (MESH:D011419), hydrogen peroxide (MESH:D006861), BKCa (-), hydrogen sulfide (MESH:D006862), NO (MESH:D009614), S (MESH:D013455), Pravastatin (MESH:D017035), Pax (MESH:C048220), Indo (MESH:D007213), lipids (MESH:D008055), I (MESH:D007455), peroxynitrite (MESH:D030421), reactive oxygen species (MESH:D017382), Calcium (MESH:D002118), SKA-31 (MESH:C535212), sodium nitroprusside (MESH:D009599)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12976587/full.md

---
Source: https://tomesphere.com/paper/PMC12976587